Rigel Pharmaceuticals Inc. (New) (RIGL)
PHARMACEUTICAL PREPARATIONS
Rigel Pharmaceuticals Inc. (New) (RIGL) is listed on Nasdaq, where it has traded since November 29, 2000.
- Listed On
- Nasdaq
- Listed Since
- November 29, 2000
- Employees
- 174
- Market Cap
- $913M
About Rigel Pharmaceuticals Inc. (New)
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 151 institutions reported holding RIGL, with 16.3 million shares worth $637.0 million in aggregate. The largest reported holder was BlackRock, with 1.9 million shares worth $75.9 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 1,939,818 | $76M | Added 9.66% |
| Soleus Capital Management | 1,843,504 | $72M | Added 18335.04% |
| Armistice Capital | 1,672,000 | $65M | Added 30.63% |
| Vanguard | 1,164,833 | $46M | Added 9.73% |
| State Street | 1,039,994 | $41M | Reduced 7.16% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is RIGL?
Rigel Pharmaceuticals Inc. (New) (RIGL) is listed on Nasdaq, where it has traded since November 29, 2000.
Who are the largest institutional holders of RIGL?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of RIGL were BlackRock, Soleus Capital Management and Armistice Capital.
How many institutions own RIGL?
151 institutions reported a position in RIGL for the quarter ended June 30, 2026, worth $637.0 million in total.
Did institutions buy or sell RIGL last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for RIGL.
Every reported institutional holder, plus insider and congressional trades in RIGL, on SentiSense.